Loading clinical trials...
Loading clinical trials...
Open-label, Randomized, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Budesonide Novolizer Dry Powder Inhaler Compared With Budesonide Turbuhaler Dry Powder Inhaler in Chinese Mild to Moderate Asthma Patients
Conditions
Interventions
Budesonide dry powder inhaler
Locations
11
China
The Second Artillery General Hospital of PLA
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Foshan
Foshan, Guangdong, China
Guangzhou First Municipal People's Hospital
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangzhou Medical College, Guangzhou Institute of Respiratory Disease
Guangzhou, Guangdong, China
Zhongda Hospital of Southeast University
Nanjing, Jiangsu, China
Shengjing Hospital
Shenyang, Liaoning, China
Start Date
December 1, 2010
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2011
Last Updated
August 23, 2011
NCT07219173
NCT02327897
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
NovaMed Pharmaceuticals Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions